Meisner Derek M
SEC CIK 1752461 · EDGAR
BoughtSold
Most active insiders at ABOS, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Meisner Derek M | CLO, Corp Sec | — | $248.8K |
| 2 | OConnell Daniel Joseph | CEO, Dir | — | $163.2K |
| 3 | Porter Derrell | Dir | — | $75.2K |
| 4 | Zuga Matt | CFO, Chief Business Off | — | $49.6K |
| 5 | Barton Russell | COO | — | $30.0K |
| 6 | Siemers Eric | Chief Medical Off | — | $27.1K |
| 7 | Doherty James J. | Pres, CDO | — | $15.2K |
| 8 | Fountain Nathan B | Dir | — | $14.3K |
| 9 | Schacterle Amy | Chief Regulatory Off | — | $2,172 |
| 10 | Stoppel Laura | Dir | — | — |
Transactions 22
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-03-10 | 2026-03-06 | ABOS | Acumen Pharmaceuticals, Inc. | Meisner Derek M | CLO, Corp Sec | M - OptEx | $1.85 | +2,090 | 176.1K | +1% | +$3,866 |
| D | 2026-03-10 | 2026-03-06 | ABOS | Acumen Pharmaceuticals, Inc. | Meisner Derek M | CLO, Corp Sec | S - Sale+OE | $3.26 | -2,090 | 174.0K | -1% | -$6,813 |
| D | 2026-03-03 | 2026-02-27 | ABOS | Acumen Pharmaceuticals, Inc. | Meisner Derek M | CLO, Corp Sec | M - OptEx | $1.85 | +9,406 | 183.4K | +5% | +$17.4K |
| D | 2026-03-03 | 2026-02-27 | ABOS | Acumen Pharmaceuticals, Inc. | Meisner Derek M | CLO, Corp Sec | S - Sale+OE | $3.01 | -9,406 | 174.0K | -5% | -$28.3K |
| DM | 2026-01-28 | 2026-01-26+ | ABOS | Acumen Pharmaceuticals, Inc. | Meisner Derek M | CLO, Corp Sec | M - OptEx | $1.85 | +17.8K | 189.1K | +10% | +$32.8K |
| DM | 2026-01-28 | 2026-01-26+ | ABOS | Acumen Pharmaceuticals, Inc. | Meisner Derek M | CLO, Corp Sec | S - Sale+OE | $3.00 | -17.8K | 174.0K | -9% | -$53.3K |
| M | 2026-01-23 | 2026-01-21+ | ABOS | Acumen Pharmaceuticals, Inc. | Meisner Derek M | CLO, Corp Sec | S - Sale | $1.87 | -8,934 | 174.0K | -5% | -$16.7K |
| D | 2026-01-21 | 2026-01-16 | ABOS | Acumen Pharmaceuticals, Inc. | Meisner Derek M | CLO, Corp Sec | A - Grant | $0.00 | +99.1K | 182.9K | +118% | $0 |
| M | 2026-01-12 | 2026-01-08+ | ABOS | Acumen Pharmaceuticals, Inc. | Meisner Derek M | CLO, Corp Sec | S - Sale | $1.80 | -50.7K | 127.6K | -28% | -$90.9K |
| M | 2026-01-07 | 2026-01-05+ | ABOS | Acumen Pharmaceuticals, Inc. | Meisner Derek M | CLO, Corp Sec | S - Sale | $1.98 | -26.7K | 144.5K | -16% | -$52.7K |
| 2025-01-23 | 2025-01-21 | ABOS | Acumen Pharmaceuticals, Inc. | Meisner Derek M | CLO, Corp Sec | S - Sale | $1.59 | -3,418 | 161.1K | -2% | -$5,435 | |
| D | 2025-01-07 | 2025-01-06 | ABOS | Acumen Pharmaceuticals, Inc. | Meisner Derek M | CLO, Corp Sec | A - Grant | $0.00 | +66.8K | 164.5K | +68% | $0 |
| D | 2025-01-07 | 2025-01-03 | ABOS | Acumen Pharmaceuticals, Inc. | Meisner Derek M | CLO, Corp Sec | S - Sale | $1.84 | -11.1K | 97.7K | -10% | -$20.5K |
| 2024-01-19 | 2024-01-19 | ABOS | Acumen Pharmaceuticals, Inc. | Meisner Derek M | CLO, Corp Sec | S - Sale | $3.48 | -8,933 | 108.9K | -8% | -$31.1K | |
| D | 2024-01-04 | 2024-01-02 | ABOS | Acumen Pharmaceuticals, Inc. | Meisner Derek M | CLO, Corp Sec | A - Grant | $0.00 | +91.0K | 117.8K | +340% | $0 |
| D | 2023-01-18 | 2023-01-17 | ABOS | Acumen Pharmaceuticals, Inc. | Meisner Derek M | Chief Legal Office, Corp Sec | A - Grant | $0.00 | +26.8K | 26.8K | New | $0 |
| 2022-08-19 | 2022-08-17 | XFOR | X4 Pharmaceuticals, Inc | Meisner Derek M | CLO | S - Sale | — | -8,334 | 145.2K | -5% | — | |
| 2022-06-27 | 2022-06-24 | XFOR | X4 Pharmaceuticals, Inc | Meisner Derek M | CLO | S - Sale | — | -4,166 | 153.5K | -3% | — | |
| 2022-06-17 | 2022-06-16 | XFOR | X4 Pharmaceuticals, Inc | Meisner Derek M | CLO | S - Sale | — | -4,166 | 157.7K | -3% | — | |
| 2022-03-01 | 2022-03-01 | XFOR | X4 Pharmaceuticals, Inc | Meisner Derek M | CLO | A - Grant | $0.00 | +105.0K | 161.8K | +185% | $0 | |
| 2022-02-14 | 2022-02-11 | XFOR | X4 Pharmaceuticals, Inc | Meisner Derek M | CLO | S - Sale | — | -15.9K | 56.8K | -22% | — | |
| 2021-08-19 | 2021-08-17 | XFOR | X4 Pharmaceuticals, Inc | Meisner Derek M | GC | S - Sale | $5.10 | -8,332 | 72.7K | -10% | -$42.5K |
Purchase Sale Sale after option exercise All abbreviations